USE OF HERBAL SUPPLEMENTS AND POTENTIAL DRUG INTERACTIONS IN CANCER PATIENTS: A CROSS-SECTIONAL INVESTIGATION.
DOI:
https://doi.org/10.51168/sjhrafrica.v6i3.1684Keywords:
Herbal Supplements, Cancer, Drug Interactions, Awareness, CommunicationAbstract
Background
The use of herbal supplements among cancer patients has become increasingly prevalent, raising concerns about potential drug interactions that may compromise treatment outcomes and patient safety. Although herbal supplements are often perceived as natural and harmless, they can interact with cancer therapies, potentially altering drug metabolism and efficacy.
Objective
This study aimed to evaluate the prevalence, types, and patterns of herbal supplement use among cancer patients, assess potential drug interactions with prescribed cancer treatments, and determine the level of awareness and communication regarding supplement use.
Methods
A descriptive cross-sectional study was conducted at the Konaseema Institute of Medical Sciences and Research Foundation, Amalapuram, from January to June 2023. A structured questionnaire was used to survey 200 adult cancer patients undergoing active treatment. Descriptive statistics and logistic regression analysis were used to evaluate associations.
Results
Of the 200 patients, 60% reported using herbal supplements during cancer treatment. The most commonly used supplements were St. John’s Wort (20%), Ginger (17.5%), and Turmeric (12.5%). 25% of patients experienced potential herb-drug interactions, including increased toxicity (15%) and reduced treatment efficacy (10%). Only 35% of patients disclosed herbal supplement use to their healthcare providers, while 65% did not, primarily due to perceived irrelevance or fear of disapproval.
Conclusion
A substantial proportion of cancer patients use herbal supplements alongside prescribed treatments, often without informing their healthcare providers. This practice poses risks of adverse drug interactions and reduced therapeutic efficacy.
Recommendations
Cancer care providers should integrate routine inquiry about herbal supplement use into patient assessments. Increased patient education is essential to help patients understand the potential risks and make informed decisions. Improved communication and awareness can enhance treatment safety and outcomes.
References
Lam CS, Hua R, Au-Doung PL, Wu YK, Koon HK, Zhou KR, Loong HH, Chung VC, Cheung YT. Association between potential supplement-drug interactions and liver diseases in patients with cancer: A large prospective cohort study. Clin Nutr ESPEN. 2023 Dec 1;58:152-9. https://doi.org/10.1016/j.clnesp.2023.09.919
Lam CS, Milosavljevic A, Barnes J, Cheung YT. Potential interactions between herbal or other non-vitamin non-mineral supplements and drugs among patients diagnosed with cancer: A UK Biobank study. Drug Saf. 2023 Apr 1;46(4):425-6.
Chan WJ, Adiwidjaja J, McLachlan AJ, Boddy AV, Harnett JE. Interactions between natural products and cancer treatments: Underlying mechanisms and clinical importance. Cancer Chemother Pharmacol. 2023 Feb;91(2):103-19. https://doi.org/10.1007/s00280-023-04504-z
Bazrafshani MS, Pardakhty A, Kalantari Khandani B, Tajadini H, Ghazanfari Pour S, Hashemi S, Amiri S, Mehmandoost S, Beigzadeh A, Abbaszadeh S, Sharifi H. The prevalence and predictors of herb-drug interactions among Iranian cancer patients during chemotherapy courses. BMC Complement Med Ther. 2023 Feb 7;23(1):41. https://doi.org/10.1186/s12906-023-03869-1
Dores AR, Peixoto M, Castro M, Sá C, Carvalho IP, Martins A, Maia E, Praça I, Marques A. Knowledge and beliefs about herb/supplement consumption and herb/supplement-drug interactions among the general population, including healthcare professionals and pharmacists: A systematic review and guidelines for a smart decision system. Nutrients. 2023 May 13;15(10):2298. https://doi.org/10.3390/nu15102298
Allegra S, De Francia S, Turco F, Bertaggia I, Chiara F, Armando T, Storto S, Mussa MV. Phytotherapy and drugs: Can their interactions increase side effects in cancer patients? J Xenobiotics. 2023 Feb 1;13(1):75-89. https://doi.org/10.3390/jox13010007
Mudyiwa M, Sharma M, Ray SK, Masimirembwa C, Thelingwani RS. Inhibitory effects of herbal medicines with claimed anticancer indications on cytochrome P450-An evaluation of drug-herb interactions risk. Sci Afr.. 2023 Sep 1;21:e01835. https://doi.org/10.1016/j.sciaf.2023.e01835
Kuriachan S, Palatty PL, George T, Baliga MS. Adverse drug reaction reporting in geriatric oncology in India: An understudied topic that needs attention. Indian J Med Paediatr Oncol. 2023,44 (4):385-389 https://doi.org/10.1055/s-0043-1768569
Doke CO, Tiwari RS, Todekar VB, Mane AP, Sawant VS, Sawant GV. Herb-drug interaction in antibiotic drugs, antiulcer drugs, antihypertensive drugs, antidiabetic drugs, and anticancer drugs. Res J Sci Technol. 2023;15(2):119-26. https://doi.org/10.52711/2349-2988.2023.00020
Gidwani B, Tiwari S, Jain V, Joshi V, Pandey R, Shukla SS, Agrawal K, Chauhan NS, Vyas A. Herbal drug interaction and effects on phytopharmaceuticals. In: Phytopharmaceuticals and Herbal Drugs. Academic Press; 2023 Jan 1. p. 249-64. https://doi.org/10.1016/B978-0-323-99125-4.00015-9
Mudyiwa M, Sharma M, Ray SK, Masimirembwa C, Thelingwani RS. Inhibitory effects of herbal medicines with claimed anticancer indications on cytochrome P450-An evaluation of drug-herb interactions risk. Sci Afr.. 2023 Sep 1;21:e01835. https://doi.org/10.1016/j.sciaf.2023.e01835
Choudhury A, Singh PA, Bajwa N, Dash S, Bisht P. Pharmacovigilance of herbal medicines: Concerns and prospects. J Ethnopharmacol. 2023 Mar12:116383. https://doi.org/10.1016/j.jep.2023.116383
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Nageswara Rao T, Munikumar K , Yakaiah Vangoori, Suresh Babu Sayana, Srinivas Anthireddy
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
